GSK Aug 2022 30.000 call
| Previous close | 10.90 |
| Open | 10.90 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 30.00 |
| Expiry date | 2022-08-19 |
| Day's range | 10.90 - 10.90 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Business Wire
ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide
PHILADELPHIA, August 08, 2022--GSK plc (LSE/NYSE: GSK) today announced the launch of Vaccine Track, a comprehensive platform developed by GSK and IQVIA for use by public health officials, industry leaders and medical professionals to strengthen vaccination data transparency, raise awareness and publicly share vaccination trends to aid improvements in routine adult vaccinations to create healthier communities across the US. This resource will provide frequent and relevant data on trends to focus
- Zacks
Theravance's (TBPH) Q2 Earnings Beat, Focus on Pipeline
Theravance (TBPH) reports narrower-than-expected loss in the second quarter of 2022. Revenues improve year over year due to Viatris collaboration.
- Zacks
Gilead (GILD) Q2 Earnings & Sales Top, Revenue Outlook Upped
Gilead (GILD) reports better-than-expected second quarter results on strong HIV business. The company also raises its annual revenue guidance.
